09/14/2026
Entropy Neurodynamics was recently granted a South African patent for treating fibromyalgia with psilocybin and psilocin, with protection extending through 2043.
Targeted IP: The patent does not claim ownership over the naturally occurring compounds themselves; it strictly covers specific therapeutic methods and treatment protocols.
Industry Trend: As psychedelic-assisted therapy enters commercial healthcare, companies are racing to patent custom formulations, delivery systems, and specific medical indications.
The Core Debate: Strong intellectual property rights provide the financial incentive required to fund costly clinical trials. However, it sparks a vital question regarding how much of this space will remain in the public domain versus behind corporate paywalls.
An ancient medicine adapting to a very modern pharmaceutical business model.